BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31229434)

  • 1. Synergistic Enhancement of Cellular Uptake With CD44-Expressing Malignant Pleural Mesothelioma by Combining Cationic Liposome and Hyaluronic Acid-Lipid Conjugate.
    Sakurai Y; Kato A; Hida Y; Hamada J; Maishi N; Hida K; Harashima H
    J Pharm Sci; 2019 Oct; 108(10):3218-3224. PubMed ID: 31229434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.
    Cortes-Dericks L; Schmid RA
    Respir Res; 2017 Apr; 18(1):58. PubMed ID: 28403901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemetrexed-conjugated hyaluronan for the treatment of malignant pleural mesothelioma.
    Amano Y; Ohta S; Sakura KL; Ito T
    Eur J Pharm Sci; 2019 Oct; 138():105008. PubMed ID: 31302213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
    Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
    J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hyaluronic acid and CD44 interaction on the proliferation and invasiveness of malignant pleural mesothelioma.
    Hanagiri T; Shinohara S; Takenaka M; Shigematsu Y; Yasuda M; Shimokawa H; Nagata Y; Nakagawa M; Uramoto H; So T; Tanaka F
    Tumour Biol; 2012 Dec; 33(6):2135-41. PubMed ID: 22886525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of let-7a microRNA encapsulated ephrin-A1 conjugated liposomal nanoparticles inhibit tumor growth in lung cancer.
    Lee HY; Mohammed KA; Kaye F; Sharma P; Moudgil BM; Clapp WL; Nasreen N
    Int J Nanomedicine; 2013; 8():4481-94. PubMed ID: 24293999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed.
    Ando H; Kobayashi S; Abu Lila AS; Eldin NE; Kato C; Shimizu T; Ukawa M; Kawazoe K; Ishida T
    J Control Release; 2015 Dec; 220(Pt A):29-36. PubMed ID: 26476173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.
    Alì G; Borrelli N; Riccardo G; Proietti A; Pelliccioni S; Niccoli C; Boldrini L; Lucchi M; Mussi A; Fontanini G
    J Thorac Oncol; 2013 Nov; 8(11):1389-95. PubMed ID: 24084442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells.
    Tajima K; Ohashi R; Sekido Y; Hida T; Nara T; Hashimoto M; Iwakami S; Minakata K; Yae T; Takahashi F; Saya H; Takahashi K
    Oncogene; 2010 Apr; 29(13):1941-51. PubMed ID: 20101228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma.
    Fujimoto N; Gemba K; Asano M; Fuchimoto Y; Wada S; Ono K; Ozaki S; Kishimoto T
    Respir Investig; 2013 Jun; 51(2):92-7. PubMed ID: 23790737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS; Chen CW; Lin CA; Yu HP; Lin HY; Liao MY; Wu SH; Lin YF; Lai PS
    Int J Nanomedicine; 2017; 12():2315-2333. PubMed ID: 28392690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.
    Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B
    J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
    Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan Reduces Cationic Liposome-Induced Toxicity and Enhances the Antitumor Effect of Targeted Gene Delivery in Mice.
    Qian Y; Liang X; Yang J; Zhao C; Nie W; Liu L; Yi T; Jiang Y; Geng J; Zhao X; Wei X
    ACS Appl Mater Interfaces; 2018 Sep; 10(38):32006-32016. PubMed ID: 30156827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic Treatment of Malignant Pleural Mesothelioma].
    Nakano T
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2041-2047. PubMed ID: 29361614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.
    Nascimento TL; Hillaireau H; Vergnaud J; Fattal E
    Nanomedicine (Lond); 2016 Jul; 11(14):1865-87. PubMed ID: 27389568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
    Cortes-Dericks L; Froment L; Boesch R; Schmid RA; Karoubi G
    BMC Cancer; 2014 Apr; 14():304. PubMed ID: 24884875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems.
    Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K
    Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
    Sargazi A; Shiri F; Keikha S; Majd MH
    Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.